Skip to main content
. Author manuscript; available in PMC: 2012 Oct 24.
Published in final edited form as: Cancer. 2011 Oct 24;118(12):3079–3086. doi: 10.1002/cncr.26609

Table 3.

Medicare payments in first year after prostate cancer surgery, patients with positive costs*

Category MRP
(N=991)
ORP
(N=4,454)
Difference
n Mean (SD) n Mean (SD) Mean (SD) p
Total 991 $16,919 $20,510 4454 $15,692 $12,720 $1,227 $14,452 0.08
 Surgery 991 $10,968 $13,647 4454 $10,217 $5,944 $751 $7,923 0.02
 Other cancer therapy
  Chemotherapy/bisphosphonates 52 $1,870 $3,231 327 $2,813 $3,872 −$943 $3,792 0.01
  Radiotherapy 65 $4,690 $8,170 373 $5,822 $8,713 −$1,132 $8,635 0.18
  Androgen deprivation therapy - $410 ----- 26 $1,406 $1,239 −$996 $1,239 -----
 Inpatient care 129 $20,415 $26,238 664 $14,361 $15,631 $6,054 $17,782 0.03
 Other
  Home health care 269 $1,097 $1,829 586 $1,945 $1,750 −$848 $1,776 <.0001
  Other 986 $2,602 $3,112 4433 $2,387 $2,884 $215 $2,927 0.67
*

Notes: Mean for each category based on observations with costs greater than $0 within category.

Cells with counts ≤11 and relevant adjacent cells are not shown, in adherence with SEER-Medicare Data Use Agreement

All costs in 2006 US dollars, adjusted for inflation and geographic variability.

P-values for tests of difference in mean of natural log of costs.

MRP: minimally invasive radical prostatectomy

ORP: open radical prostatectomy